Mandy Moore's RSV Scare: How It Changed Her & New Hope for Babies!

Mandy Moore's RSV Scare: How It Changed Her & New Hope for Babies! - Imagen ilustrativa del artículo Mandy Moore's RSV Scare: How It Changed Her & New Hope for Babies!

Mandy Moore is opening up about a terrifying experience: both of her sons, August "Gus" Harrison and Oscar "Ozzie" Bennett, were diagnosed with Respiratory Syncytial Virus (RSV) in 2023. In a recent interview, the actress shared how "helpless" she felt during the ordeal, even though thankfully, they didn't require hospitalization. This experience significantly impacted her approach to parenting, making her more proactive about her children's health.

A Mother's Fear: RSV Strikes

Moore and her husband, Taylor Goldsmith, are now parents to three children, including daughter Louise "Lou" Everett. The RSV scare prompted them to explore preventative measures, especially with a new baby on the way. This led them to BEYFORTUS®, a new RSV prevention treatment.

BEYFORTUS®: A New Weapon Against RSV

Sanofi, a global healthcare company, has partnered with Mandy Moore and other celebrity mothers to raise awareness about BEYFORTUS®. This long-acting monoclonal antibody is approved to prevent serious RSV lung infections in babies up to 24 months old. It's designed for all babies, regardless of their health status or birth timing, offering a broad shield against this common and potentially dangerous virus.

Clinical studies and real-world data involving over 400,000 babies demonstrate the safety and effectiveness of BEYFORTUS®. RSV is the leading cause of hospitalization in infants under one year old, making preventative measures crucial. BEYFORTUS® is gaining traction as a doctor-prescribed option for RSV protection.

Cost-Effectiveness Confirmed

Recent research from Korea evaluating the cost-effectiveness of Beyfortus (nirsevimab) for infants and young children was published in the journal *Human Vaccines & Immunotherapeutics*. The study compared administering Beyfortus to all infants under one year and high-risk infants under two years against the existing strategy of only treating high-risk infants with a preventive antibody injection (palivizumab). The results showed that using Beyfortus universally reduced unnecessary medical costs and caregiver burden.

A United Front: Celebrities Join the Fight

Mandy Moore's personal story, along with the support of other celebrity mothers, is helping to highlight the importance of RSV prevention. Sanofi's campaign features these personal narratives, emphasizing BEYFORTUS® as a proactive step parents can take to protect their children's health.

What is RSV?

  • Respiratory Syncytial Virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms.
  • However, RSV can be serious, especially for infants and older adults.
  • In infants, RSV can lead to bronchiolitis (inflammation of the small airways in the lungs) and pneumonia (infection of the lungs).

Share Article